The Food and Drug Administration is expected to authorize boosters of the Moderna and Johnson & Johnson COVID-19 vaccines by Oct. 20, at which time it could also allow the mix and match of boosters.
The retailer is joining forces with Sarasota Memorial Hospital-Venice to offer bedside delivery of prescriptions before patients are discharged when the hospital opens in November.
The Food and Drug Administration originally approved Cyltezo in 2017 for the treatment of multiple chronic inflammatory diseases and this latest approval designates it as interchangeable across all of these indications.